Navigation Links
Positive Results Published Using AtriCure Minimally Invasive Products
Date:1/7/2008

WEST CHESTER, Ohio, Jan. 7 /PRNewswire-FirstCall/ -- AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation products, today announced that results reporting on the Company's proprietary minimally invasive products, which physicians have adopted to treat atrial fibrillation (AF), were published in The Annals of Thoracic Surgery by Dr. James H. Wudel, a prominent cardiac surgeon, and colleagues from the Nebraska Heart Hospital, Lincoln, Nebraska.

Dr. Wudel reported the results from 22 patients with symptomatic, drug refractory, intermittent AF who underwent a video assisted, minimally invasive, thoracoscopic pulmonary vein isolation procedure using the AtriCure minimally invasive bipolar ablation system. Additionally, in 21 of the 22 patients, the left atrial appendage was removed.

Of the 22 symptomatic, drug refractory, intermittent AF patients, 8 patients presented with persistent AF and 14 patients presented with paroxysmal AF. All 22 patients were followed for a minimum of one year with an average follow-up of eighteen months. Holter monitoring was applied at the final follow-up to more accurately determine the rhythm status.

At the final follow-up, 20 patients (91%) were in normal sinus rhythm and off antiarrhythmic drugs. Additionally, 20 patients (91%) were no longer taking warfarin at the end of the study period.

Dr. James H. Wudel commented, "These promising minimally invasive products and techniques provided desirable results and are a viable option for selected AF patients. On average our length of hospital stay was three days and our patients went home to an improved quality of life. We look forward to the continued development of these minimally invasive too
'/>"/>

SOURCE AtriCure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
4. BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
5. DURECT Announces Positive ELADUR(TM) Phase IIa Study Results
6. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
7. Chroma Announces Positive Phase I Efficacy Data for Novel Cancer Therapy CHR-2797
8. UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
9. Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
10. Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
11. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...swire-FirstCall/ -- BioCryst Pharmaceuticals, Inc.... public offering of 5,000,000 shares of its common...eeds of $48.75 million. All of the shares are bei...elf registration statement previously filed with t...as also granted the underwriters a 30-day option t...
(Date:11/19/2009)...wire-FirstCall/ -- In a series of new initiatives ...ation (Nasdaq: HSKA ) ("Heska" or the "Company") ... website. The upgraded site is the result of seve...align the site with the company,s new brand image ...ww.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,...
(Date:11/19/2009)...Newswire-FirstCall/ -- Alexza Pharmaceuticals, Inc...ate presentation will be webcast live during the 2... Wednesday, December 2, 2009 at 9:00 a.m. Eastern ...ew York Palace Hotel in New York and will be prese... ,, To access the live presentation via the We...
Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3MedEncentive and Medical Justice Announce Partnership 57097 1MedEncentive and Medical Justice Announce Partnership 57097 2MedEncentive and Medical Justice Announce Partnership 57097 3MedEncentive and Medical Justice Announce Partnership 57097 4Nuvilex Inc Announces Positive Oraphyte 28TM 29 Microplot Results 57093 1Nuvilex Inc Announces Positive Oraphyte 28TM 29 Microplot Results 57093 2Nuvilex Inc Announces Positive Oraphyte 28TM 29 Microplot Results 57093 3Nuvilex Inc Announces Positive Oraphyte 28TM 29 Microplot Results 57093 4Life Saving Alternative to the Smoke Alarm Wins the 2009 James Dyson Award 57090 1Life Saving Alternative to the Smoke Alarm Wins the 2009 James Dyson Award 57090 2Life Saving Alternative to the Smoke Alarm Wins the 2009 James Dyson Award 57090 3
...ists at NanoBio Corp. and,the University of Michi...r,novel topical nanoemulsion kills the highly resi...ss and death among individuals with cystic fibrosi... represent a new model for,treating resistant bact...th,cystic fibrosis, according to the study authors...
...acting the Treatment of Women,s Cancers? , , CHIC...one of the fastest growing technological advances ...ew years. This minimally-invasive surgery (MIS) te...e in the future of women,s cancer care will be som...necologic Oncologists, (SGO) 2009 Annual Meeting o...
Other Medicine Technology:Nanoemulsion Kills Highly Resistant Bacteria Found in Patients With Cystic Fibrosis 2Nanoemulsion Kills Highly Resistant Bacteria Found in Patients With Cystic Fibrosis 3Society of Gynecologic Oncologists 40th Annual Meeting on Women's Cancer to Include Sessions on Robotics Surgery 2Society of Gynecologic Oncologists 40th Annual Meeting on Women's Cancer to Include Sessions on Robotics Surgery 3
(Date:11/22/2009)...he holiday season is filled with get-togethers wit...s. It can also be stressful and tiring at times. E...gue, and high fat foods -- factors that can, over ... National Foundation for Cancer Research has devel...re a happier, more healthful holiday season, and c...
(Date:11/21/2009)...provides for an unprecedented expansion of federal...t is not for preserving and protecting human life?... Charmaine Yoest ,, WASHINGTON, Nov. 21 /PRN...ction President and CEO Dr. Charmaine Yoest respon...he following statement: ,, "This was a pro-abo...
(Date:11/21/2009)...H based medical credentialing software company Int...m a partnerhsip with Amerinet, Inc., the leading h...l help to transform quality care within the health...vember 21, 2009 -- ISG Group, LLC, doing business ...t with Amerinet Inc., a leading national healthcar...
(Date:11/21/2009)...inwood Group ask whether there is a secret to ,alc... London, UK (PRWEB) November 2...e in three of the adult UK population drinking eno...-related liver disease*, it is hardly a surprise t...n programmes and residential centres for help. How...
(Date:11/20/2009)...ov. 20 Following a recall by Unile...d from sale Shedd,s Country Crock ® Side Dish...y Crock ® Side Dishes DELUXE Four Cheese Past...e following code dates and UPCs are affected: ,... Cheddar Broccoli Rice 21 oz, UPC 027400218316, Be...
Breaking Medicine News(10 mins):Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2
...dustry group says, ,Think twice before mixing once...thDay News) -- Mixing your own cleaning products a... and Detergent Association warns consumers that i... those made with natural products, could cause har...
... FDA medical device approv... take much longer than anticipated due to common m...some of those mistakes. , ... the product cleared through the FDA. Most compani...
... Security network selected... Freeport, NY (PRWEB) Apri...is pleased to announce it has won the award for Be... Vegas, this highly coveted award honors Smith &am...
..., BIRMINGHAM, Ala. Researchers at the University ...r Center have been awarded a $6.4 million grant fr...ng in the fight against an aggressive and difficul...er Foundation. , The $6.4 million will be used to...
...ST. LOUIS, April 10 Sigma-Aldrich (Nasdaq: SIAL...el Kanan as Vice President and Corporate Controlle...s Karen Miller who was recently promoted to Vice P...two decades of financial experience in assignments...
...ovirus seeks out and destroys tumor cells, researc...ews) -- A common, harmless human virus can target ...chers report. , "We suspected that reovirus might ...earcher at Dalhousie Medical School in Halifax, No...
Other Medicine News:Health News:Cleaning Concoctions Best Left to Experts 2Health News:Five Tips for Quick FDA 510k Clearance for Medical Devices 2Health News:Five Tips for Quick FDA 510k Clearance for Medical Devices 3Health News:Smith & Wesson Security Services Wins Top Honors at SAMMY awards 2Health News:Smith & Wesson Security Services Wins Top Honors at SAMMY awards 3Health News:UAB wins $6.4 million nonprofit grant to fight aggressive breast cancer 2Health News:Sigma-Aldrich Announces Appointment of Michael Kanan as Vice President and Corporate Controller 2Health News:Harmless Virus May Be Deadly to Breast Cancer 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: